Treatment

Strategic Target Adjustment Revamps Antibiotic Development

12/21/2016

TXA-709 is a new type of antibiotic being developed by TAXIS Pharmaceuticals. The antibiotic specifically targets variants of the MRSA bacteria. TXA-709, a FtsZ-targeting benzamide prodrug, should be able to circumvent the problem of antibiotic resistance in certain bacterial infections by targeting previously neglected portions of these harmful microbes.

Rather than formulating a slightly different version of a previously effective antibiotic, TAXIS scientists are synthesizing new chemical entities with uniques mechanisms of action. This approach offers a distinct advantage when designing treatments to overcome multi-drug resistant bacteria. TXA-709 has yielded very promising results in pre-clinical trials. If approved, the drug will have the added benefit of being orally efficacious, which will make it easy to administer to patients.

For more videos, visit our partners at The Doctor's Channel.

Related Content

Stress and Burnout
Stress and Burnout
Seth Martin, MD, MHS, on How I Practice Now: The Future Is Now for Telemedicine
11/24/2020
In this video, Cardiology Consultant Advisory Board Member Seth Martin, MD, MHS, shares his experience with the implementation of telemedicine during the COVID-19 pandemic. 
11/24/2020
Stress and Burnout
Stress and Burnout
How I Practice Now: Telehealth Tips and 5 Ways to Keep Healthy During the Pandemic
04/13/2020
In this video, Cardiology Consultant Advisory Board Member Andrew Freeman, MD, lists 5 things you should do each day to care for yourself so that you can better care for your patients. He also provides...
04/13/2020
Nephrology
matera
Nephrology
James Matera, DO, on the Spectrum of NASH and NAFLD for Primary Care Providers
11/05/2020
James Matera, DO, discussed the differences between NASH and NAFLD, the epidemiology and clinical presentation, and treatment options.
11/05/2020
Nutrition
Nutrition
Phil Lempert on the FDA's Definition of "Healthy"
05/18/2021
In this video, Phil Lempert discusses the history of the FDA's definition of "healthy" and the use of the term on food labeling.
05/18/2021
Traumatic Brain Injury
Christina Master, MD
Traumatic Brain Injury
Christina Master, MD, on Advances in Diagnostic and Treatment Research in Sports Concussion
08/26/2017
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for...
08/26/2017